ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 661205 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 661205; 2) Community: the network communities that were significantly associated with the response to NSC 661205; 3) Molecule: the relationships between components within communities and NSC 661205; 4) MDR: the compounds that were significantly associated with the NSC 661205.

NSC Compound Enrichment Correlation
NSC 709483 Null 0.0138010872611484 0.19993686
NSC 714379 Null 0.0138010872611484 0.34657139
NSC 720386 Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.0138010872611484 0.044231474
NSC 723548 Null 0.0138010872611484 0.28952157
NSC 735030 Null 0.0138010872611484 0.2870812
NSC 740 Methotrexate 0.0138010872611484 0.41647257
NSC 743528 Null 0.0138010872611484 0.22693259
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0138010872611484 0.26148067
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0138010872611484 0.38938945
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0138010872611484 0.16159646
Total:102  Current:40    [First] [Prev] [Next] [Last]